Hideki Sakashita
Kurume University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideki Sakashita.
European Journal of Vascular and Endovascular Surgery | 2011
Shinichi Hiromatsu; Hideki Sakashita; Teiji Okazaki; Seiji Onitsuka; Atsuhisa Tanaka; Shuji Fukunaga
OBJECTIVES The objective of this study was to evaluate and compare our perioperative outcomes for open abdominal aortic aneurysm (AAA) between the pre-endovascular aneurysm repair (pre-EVAR) and EVAR eras and to analyse whether the AAA that was excluded from EVAR could affect the perioperative outcome. MATERIALS AND METHODS The Kurume University Hospital vascular registry was reviewed to identify all patients undergoing an elective open AAA repair from January 2004 through November 2006 (pre-EVAR era, n = 99) and from December 2006 through June 2010 (EVAR era, n = 125). The early clinical outcomes between the two groups were compared. RESULTS In the EVAR era, the proportion of EVAR in all elective AAA repairs was 43.4%. The EVAR era had a significantly higher proportion of very elderly patients over 80 years of age (23.2% vs. 11.1%, P = 0.0391). The morbidity rates were similar between the two groups (22.3% vs. 24,8%) and the mortality rate was 0% for both. CONCLUSION Despite the increased complexity of OAR in the EVAR era, we believe that OAR remains a valid procedure for AAA repair.
The Japanese Journal of Thoracic and Cardiovascular Surgery | 2000
Hidetoshi Akashi; Keiichiro Tayama; Takayuki Fujino; Shuji Fukunaga; Atsuhisa Tanaka; Shinsuke Hayashi; Satoru Tobinaga; Seiji Onitsuka; Hideki Sakashita; Shigeaki Aoyagi
OBJECTIVE Retrograde perfusion is gaining acceptance as a means of cerebral protection, but it remains unclear how long the brain is protected and whether it is effective in patients with preoperative cerebrovascular disease. METHODS From January 1989 to August 1999, 205 patients--118 male and 87 female patients who ranged 12 to 86 years old, mean: 65.5 years old--underwent surgery at our hospital for aortic arch aneurysm using cerebral protection. We focused on mortality, stroke incidence and perioperative risk factor between 2 groups--selective cerebral and retrograde cerebral perfusion--also studying patients with preoperative cerebrovascular disease that influenced postoperative stroke. RESULTS The hospital mortality was 11.7% (selective cerebral perfusion group: 12%, retrograde group: 10.9%). Stroke occurred in 11 patients (5.3%), 4.7% in the selective cerebral perfusion group and 7.3% in the retrograde group. Preoperative cerebrovascular disease does not appear to be a risk factor for postoperative brain damage in aortic arch surgery. Regarding total replacement of the aortic arch, the incidence of postoperative brain damage in the retrograde group with preoperative cerebrovascular disease was higher than that in another group (p = 0.072). Cardiopulmonary bypass time and selective cerebral perfusion time in the patients with postoperative stroke were significantly longer than that in non-stroke group. CONCLUSIONS Preoperative cerebrovascular disease did not appear to be a risk factor in postoperative neurological deficit in the selective cerebral perfusion group. Prolonged selective cerebral perfusion time and cardiopulmonary bypass time may, however, lead to brain edema and cause neurological deficit.
Brain Research | 2006
Keiichi Akaiwa; Hidetoshi Akashi; Hideki Harada; Hideki Sakashita; Shinichi Hiromatsu; Tatsuhiko Kano; Shigeaki Aoyagi
Stroke is a devastating complication in cardiovascular surgery, and neuronal damage is worsened by intracranial pressure elevation caused by cerebral venous circulatory disturbances (CVCD). However, we have previously reported that CVCD before cerebral ischemia decreases the infarct area. In the present study, focal cerebral ischemia was induced in spontaneously hypertensive rats by filament insertion through the carotid artery. Rats were divided into the following four groups: sham-operated, mild or severe venous congestion (VC), and DPCPX. The DPCPX group received the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) prior to mild VC. Behavior, infarct volume, edema and S-100 protein were evaluated among the four groups. The infarct volume rates in mild VC and severe VC groups were significantly less than that in sham-operated and DPCPX groups. However, the mortality of the severe VC group worsened in a time-dependent manner. We observed a significant decrease in edema in the mild VC group compared to the DPCPX group. Behavioral scores also indicated that the mild VC group had fewer neurological deficits than the other three groups, including the DPCPX group. We were able to induce rapid cerebral protection via adenosine A1 receptor activation by administering an appropriate degree of VC prior to cerebral ischemia produced by middle cerebral artery occlusion. Our work suggests possible mechanisms by which such effective VC may lead to cerebral protection and adenosine A1 receptor activation.
Vascular and Endovascular Surgery | 2010
Shinichi Hiromatsu; Shinichi Nata; Tomokazu Ohno; Yusuke Shintani; Kurando Kanaya; Hideki Sakashita; Shuji Fukunaga; Shigeaki Aoyagi
Objectives: The purpose of this study was to evaluate and compare our recent clinical experience with temporary inferior vena cava (IVC) filters (TF) and retrievable IVC filters (RF). Materials and methods: Patients who received TF or RF implantation between October 2002 and May 2009 were studied. The early clinical outcomes between the 2 groups were compared. Results: Nonpermanent IVC filters were placed in 119 patients (34 in TF and 85 in RF). Retrieval of RF and removal of TF were successful in 98.7% and 100%, respectively. The incidence of filter-related complications for TF was significantly higher than for RF (26.5% vs 3.5%; P = .0004). However, no symptomatic pulmonary embolism (PE) was observed during filter placement. Conclusion: TF and RF provided similar protection from PE. We prefer RF because they can be left in permanently if it is impossible to remove or retrieve the filter for some reason.
Surgery Today | 2001
Hidetoshi Akashi; Keiichiro Tayama; Atsuhisa Tanaka; Seiji Onitsuka; Hideki Sakashita; Shigeaki Aoyagi
Abstract Between December 1989 and May 1998, we performed a modified method of in situ reconstruction on three of seven patients with graftenteric fistulas (GEFs) at the Kurume University Hospital. The modification involved performing an anastomosis of the infrarenal abdominal aorta and running a new prosthesis through the left side of the descending colon in the retroperitoneal cavity, and wrapping the proximal anastomosis and the proximal site of the prosthesis in the greater omentum. Good results were achieved in all three patients. We describe herein this modified method of in situ reconstruction for a GEF and summarize the case reports of these three patients.
Journal of Artificial Organs | 2000
Shigeaki Aoyagi; Eiki Tayama; Shogo Yokose; Hideki Sakashita; Shuji Fukunaga; Takemi Kawara
No long-term survivals over 20 years after valve replacement with SAM (Sakakibara-Arai-Mera) valve prostheses have been described. We report a 57-year-old woman who survived for 31 years after mitral valve replacement with the SAM valve (Type M, 5M). Echocardiography revealed remarkable dilatation of the left atrium and moderate tricuspid regurgitation. Cineradiography, however, showed no restricted or asymmetric disc movement of the SAM valve. Cardiac catheterization revealed moderate pulmonary hypertension (64/30mmHg), with a mean pulmonary capillary wedge pressure of 25mmHg and a mean transprosthetic pressure gradient of 13mmHg. The mitral valve area was calculated to be 0.9 cm2. No findings of pannus overgrowth around the SAM valve were confirmed on echocardiograms or left ventriculograms. Although the diagnosis of prosthetic valve obstruction resulting from pannus formation was suspected, the patient strongly refused replacement of the SAM valve because of her poor prognosis with bilateral breast cancer with systemic metastases. We believe that this patient may be the last living patient with the SAM valve.
Japanese Circulation Journal-english Edition | 2000
Hidetoshi Akashi; Keiichiro Tayama; Takayuki Fujino; Seiji Onitsuka; Hideki Sakashita; Shigeaki Aoyagi
Japanese Heart Journal | 2002
Shigeaki Aoyagi; Hidetoshi Akashi; Hiroyuki Otsuka; Hideki Sakashita; Teiji Okazaki; Keiichiro Tayama
Japanese Circulation Journal-english Edition | 2003
Hidetoshi Akashi; Eiki Tayama; Keiichiro Tayama; Shuji Fukunaga; Satoru Tobinaga; Hideki Sakashita; Hiroyuki Otsuka; Shigeaki Aoyagi
Circulation | 2003
Hidetoshi Akashi; Eiki Tayama; Keiichiro Tayama; Shuji Fukunaga; Satoru Tobinaga; Hideki Sakashita; Hiroyuki Otsuka; Shigeaki Aoyagi